RecruitingNCT07046585

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)


Sponsor

Natera, Inc.

Enrollment

25,000 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new blood-based colorectal cancer screening test (looking for cancer DNA in the blood) in average-risk people who are already planning to get a routine colonoscopy. The goal is to see how well this blood test compares to colonoscopy findings for detecting polyps or cancer. **You may be eligible if...** - You are 40 years or older - You are planning to get a routine colonoscopy (not for symptoms — just routine screening) - You have not had a colonoscopy in the past 9 years - You are willing to give blood samples before your colonoscopy **You may NOT be eligible if...** - You have a personal history of any cancer (except for fully treated skin basal cell or squamous cell cancers) - You have had precancerous polyps on a previous colonoscopy - You are experiencing symptoms that prompted the colonoscopy - You have inflammatory bowel disease or a hereditary cancer syndrome (like Lynch Syndrome) - You have had prior colorectal surgery (other than for diverticular disease) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Natera, Inc

Austin, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07046585


Related Trials